Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters /

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

United States. General Accounting Office.

"B-235944"--P. [1]"GAO/PEMD-90-15.""April 1990."Cover title.Includes bibliographical references (p. ...

Drug abuse : research on treatment may not address current needs : report to the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1990

"B-240367"--p.[1]Cover title."GAO/HRD-90-114""September 1990"Mode of access: Internet

Medical records privacy : access needed for health research, but oversight of privacy protections is limited : report to Congressional requesters /

United States. General Accounting Office.

"B-280657"--P. 1."GAO/HEHS-99-55.""February 1999."Cover title.Includes bibliographical references.Mo...

Adverse Drug Events: The Magnitude of Health Risk Is Uncertain Because of Limited Incidence Data

United States. General Accounting Office.

January 2000

A letter report issued by the General Accounting Office with an abstract that begins "Pursuant to a ...

Drug abuse treatment : data limitations affect the accuracy of national and state estimates of need : report to Congressional requesters /

United States. General Accounting Office.

"B-279746"--P. 1."GAO/HEHS-98-229.""September 1998."Cover title.Includes bibliographical references....

Antimicrobial resistance : data to assess public health threat from resistant bacteria are limited : report to Congressional requesters /

United States. General Accounting Office.

"B-281564"--P. 1."GAO/HEHS/NSIAD/RCED-99-132.""April 1999."Cover title.Includes bibliographical refe...

Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to Congressional committees and the Administrator of General Services /

United States. General Accounting Office.
United States. General Services Administration.

"B-276585"--P. 1."GAO/HEHS-97-60.""June 1997."Cover title.Includes bibliographical references.Mode o...

Health risk analysis : technical adequacy in three selected cases : report to the Chairman, Committee on Science, Space, and Technology, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Science, Space, and Technology.

January 1987

Running title : Health risk analysis : three case studies."B-227612."--p. [1]"GAO/PEMD-87-14.""Septe...

Public hazards from unsatisfactory medical diagnostic products, Food and Drug Administration, Department of Health, Education, and Welfare : report to the Congress /

United States. General Accounting Office.

"B-164031 (2)"--Prelim. p."MWD-75-52."Publication date stamped on cover.Cover title.Includes bibliog...

Adverse Drug Events: Substantial Problem but Magnitude Uncertain

United States. General Accounting Office.

February 2000

Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...

Environmental health risks : information on EPA's draft reassessment of dioxins : report to congressional requesters /

United States. General Accounting Office.

"April 2002."Cover title."GAO-02-515."Includes bibliographical references.Mode of access: Internet

Assessment of the Food and Drug Administration's handling of reports on adverse reactions from the use of drugs,

United States. General Accounting Office.

January 1974

Cover title."B-164031(2)."At head of title: Report to the Congress.Mode of access: Internet

Drug control : status report on counterdrug technology development : report to Congressional requesters /

United States. General Accounting Office.

Cover title."B-242554"--P. 1."GAO/NSIAD-93-104.""January 1993."Mode of access: Internet

Drug use measurement : strengths, limitations, and recommendations for improvement : report to the Chairman, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B252047-"--P. [1]."GAO/PEMD-93-18.""June 1993."Cover title.Includes bibliographical references (p. ...

Drug safety : improvement needed in FDA's postmarket decision-making and oversight process : report to Congressional requesters.

United States. Government Accountability Office.

"GAO-06-402.""March 2006."Cover title.Includes bibliographical references.Mode of access: Internet

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

United States. General Accounting Office.

"B-235944"--P. [1]"GAO/PEMD-90-15.""April 1990."Cover title.Includes bibliographical references (p. ...

Drug abuse : research on treatment may not address current needs : report to the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1990

"B-240367"--p.[1]Cover title."GAO/HRD-90-114""September 1990"Mode of access: Internet

Medical records privacy : access needed for health research, but oversight of privacy protections is limited : report to Congressional requesters /

United States. General Accounting Office.

"B-280657"--P. 1."GAO/HEHS-99-55.""February 1999."Cover title.Includes bibliographical references.Mo...

Adverse Drug Events: The Magnitude of Health Risk Is Uncertain Because of Limited Incidence Data

United States. General Accounting Office.

January 2000

A letter report issued by the General Accounting Office with an abstract that begins "Pursuant to a ...

Drug abuse treatment : data limitations affect the accuracy of national and state estimates of need : report to Congressional requesters /

United States. General Accounting Office.

"B-279746"--P. 1."GAO/HEHS-98-229.""September 1998."Cover title.Includes bibliographical references....

Antimicrobial resistance : data to assess public health threat from resistant bacteria are limited : report to Congressional requesters /

United States. General Accounting Office.

"B-281564"--P. 1."GAO/HEHS/NSIAD/RCED-99-132.""April 1999."Cover title.Includes bibliographical refe...

Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to Congressional committees and the Administrator of General Services /

United States. General Accounting Office.
United States. General Services Administration.

"B-276585"--P. 1."GAO/HEHS-97-60.""June 1997."Cover title.Includes bibliographical references.Mode o...

Health risk analysis : technical adequacy in three selected cases : report to the Chairman, Committee on Science, Space, and Technology, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Science, Space, and Technology.

January 1987

Running title : Health risk analysis : three case studies."B-227612."--p. [1]"GAO/PEMD-87-14.""Septe...

Public hazards from unsatisfactory medical diagnostic products, Food and Drug Administration, Department of Health, Education, and Welfare : report to the Congress /

United States. General Accounting Office.

"B-164031 (2)"--Prelim. p."MWD-75-52."Publication date stamped on cover.Cover title.Includes bibliog...

Adverse Drug Events: Substantial Problem but Magnitude Uncertain

United States. General Accounting Office.

February 2000

Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congre...

Environmental health risks : information on EPA's draft reassessment of dioxins : report to congressional requesters /

United States. General Accounting Office.

"April 2002."Cover title."GAO-02-515."Includes bibliographical references.Mode of access: Internet

Assessment of the Food and Drug Administration's handling of reports on adverse reactions from the use of drugs,

United States. General Accounting Office.

January 1974

Cover title."B-164031(2)."At head of title: Report to the Congress.Mode of access: Internet

Drug control : status report on counterdrug technology development : report to Congressional requesters /

United States. General Accounting Office.

Cover title."B-242554"--P. 1."GAO/NSIAD-93-104.""January 1993."Mode of access: Internet

Drug use measurement : strengths, limitations, and recommendations for improvement : report to the Chairman, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B252047-"--P. [1]."GAO/PEMD-93-18.""June 1993."Cover title.Includes bibliographical references (p. ...

Drug safety : improvement needed in FDA's postmarket decision-making and oversight process : report to Congressional requesters.

United States. Government Accountability Office.

"GAO-06-402.""March 2006."Cover title.Includes bibliographical references.Mode of access: Internet

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

United States. General Accounting Office.

"B-235944"--P. [1]"GAO/PEMD-90-15.""April 1990."Cover title.Includes bibliographical references (p. ...

Drug abuse : research on treatment may not address current needs : report to the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1990

"B-240367"--p.[1]Cover title."GAO/HRD-90-114""September 1990"Mode of access: Internet

Medical records privacy : access needed for health research, but oversight of privacy protections is limited : report to Congressional requesters /

United States. General Accounting Office.

"B-280657"--P. 1."GAO/HEHS-99-55.""February 1999."Cover title.Includes bibliographical references.Mo...

Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters /

Abstract

Extracted data

Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters /

Abstract

Extracted data

Related items

Related items